Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Why Is Allergy Therapeutics plc (LSE:AGY) Falling 3.68% Today as Investors Reassess the Latest Outlook?

• Allergy Therapeutics plc — LSE:AGY declined 3.68% on 6 October 2026 as investors continued to weigh its clinical pipeline against funding and execution risk.

Ankur Sharma | 06 October 2026

Why Is AstraZeneca Stock Rising 2.23% as Major Oncology Investments Strengthen Its Growth Story? (LSE:AZN)

LSE:AZN moved +2.23% on 6 October 2026, placing AstraZeneca Plc among the UK-listed stocks attracting notable buying interest during the session.

Ankur Sharma | 06 October 2026

Why Did AstraZeneca PLC LSE:AZN Fall 0.27% Amid a Softer Tone Across London-Listed Pharmaceutical Shares?

AstraZeneca PLC — LSE:AZN closed 0.27% lower on06 October 2026, with the shares at 102.67p after a decline of 0.27p on the day.

Ishan Mudgal | 06 October 2026

Why Did CellBxHealth plc LSE:CLBX Fall 2.29% Amid a Softer Tone Across London-Listed Healthcare Shares?

CellBxHealth plc — LSE:CLBX closed 2.29% lower on06 October 2026, with the shares at 0.8305p after a decline of 0.0195p on the day.

Ishan Mudgal | 06 October 2026

Why Did Cizzle Biotechnology Holdings plc LSE:CIZ Rise 1.33% Amid a Firmer Tone Across London-Listed Biotech Shares?

Cizzle Biotechnology Holdings plc — LSE:CIZ closed 1.33% higher on06 October 2026, with the shares at 1.52p after a rise of 0.02p on the day.

Ishan Mudgal | 06 October 2026

Why Did Diaceutics Plc LSE:DXRX Rise 1.23% Amid a Firmer Tone Across London-Listed Healthcare Shares?

Diaceutics Plc — LSE:DXRX closed 1.23% higher on06 October 2026, with the shares at 195.37p after a rise of 2.37p on the day.

Ishan Mudgal | 06 October 2026

How Renalytix (LSE:RENX) Completed Its Fundraise to Support kidneyintelX.dkd Testing With Quest Diagnostics

Renalytix describes itself as a "precision medicine diagnostics company focussed on kidney disease". Its main product is kidneyintelX.dkd, a test intended to help clinicians assess and manage kidney disease. The company has entered a multi-yearPartnershipwith Quest Diagnostics, a US laboratory services provider, under which …

Ankur Sharma | 06 October 2026

Why Creo Medical (LSE:CREO) Is Counting on Its Spanish Stake Sale After Interim Results

Creo Medical is an AIM-quoted medical technology company that develops advanced energy devices used in minimally invasive endoscopic procedures. Its products include the Speedboat device, which the company said has now been used in more than 10,000 procedures, and the MicroBlate range. Creo Medical …

Ankur Sharma | 06 October 2026

How Nuformix (LSE:NFX) Is Funding Its Search for a Licensing Partner for NXP002

Nuformix is a pharmaceutical development company whose shares are listed on the Main Market of theLondon Stock Exchangeunder the code NFX. Its lead programme, NXP002, is being developed for idiopathic pulmonary fibrosis and progressive pulmonary fibrosis, serious chronic lung diseases in which scar tissue …

Ankur Sharma | 06 October 2026

How Haleon (LSE:HLN) Refinanced Its 2027 Dollar Notes With a $2bn Three-Tranche Bond

Haleon plc (LSE:HLN) is a consumer health company whose brands span oral health, vitamins, minerals and supplements, pain relief, respiratory health, digestive health and therapeutic skin health. Its shares trade on theLondon Stock Exchangeunder the ticker HLN, and it also has a listing in …

Ankur Sharma | 06 October 2026
Support

Hi! How can we help you today?

Loading…